Cara Therapeutics (CARA)
(Delayed Data from NSDQ)
$0.30 USD
-0.01 (-2.17%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.30 0.00 (-0.66%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
CARA 0.30 -0.01(-2.17%)
Will CARA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CARA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CARA
TFF Pharmaceuticals, Inc. (TFFP) Reports Q2 Loss, Tops Revenue Estimates
Ovid Therapeutics (OVID) Q2 Earnings and Revenues Surpass Estimates
CARA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
Other News for CARA
Bullish Wednesday For Marijuana Stocks - Australis Capital, Leafbuyer Techs Among Top Gainers
Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 12, 2024
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024
CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q2 2024
Earnings week ahead: Zoom, Lowe's, Target, Baidu, XPeng, Zim Integrated and more